Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report

First Page		Document Content
Complement system Acquired hemolytic anemia Nephrology Hematopathology Hemolytic-uremic syndrome Syndromes Alexion Pharmaceuticals Factor H Complement factor I Anatomy Medicine Hematology		Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report Add to Reading List Source URL: www.jmedicalcasereports.com Download Document from Source Website File Size: 634,04 KB Share Document on Facebook

	Busek Wins NASA Cubesat Propulsion Contract Firm’s Groundbreaking Electrospray Technology in Cubesat form Factor NATICK, MA - MARCH 2, Busek today announced that its BET-100 miniature cubesat propulsion system h DocID: 1u1sa - View Document
	Modeling an autism risk factor in mice leads to permanent immune dysregulation Elaine Y. Hsiao1, Sara W. McBride, Janet Chow, Sarkis K. Mazmanian, and Paul H. Patterson Biology Division, California Institute of Technolog DocID: 1sFW7 - View Document
	The Journal of Neuroscience, November 5, 2008 • 28(45):11433–11434 • Commentary Editor’s Note: The misuse of journal impact factor in hiring and promotion decisions is a growing concern. This article is on DocID: 1rpIm - View Document
	Evolutionary Ecology Research, 2016, 17: 141–155 —ultimate revision: 12 July 2016— Are conference special issues worthwhile? Andrew P. Hendry1 and Catherine L. Peichel2 1 DocID: 1r0mc - View Document
	1 Identifying Techniques, Topologies and Features for Maximizing the Efficiency of a Distribution Grid with Solid State Power Devices Karl Stefanski, Hengsi Qin, Badrul H. Chowdhury, Senior Member, IEEE, Jonathan W. Kim DocID: 1qVOD - View Document